• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Joe Antos: CMS' Proposed MSSP Changes Don't Account for Variability in Healthcare

Video

The proposed CMS regulation to change the Medicare Shared Savings Program (MSSP) so that accountable care organizations (ACOs) take on risk faster creates a one-size-fits-all model that doesn’t allow for variability, said Joe Antos, PhD, the Wilson H. Taylor Resident Scholar in Health Care and Retirement Policy at the American Enterprise Institute.

The proposed CMS regulation to change the Medicare Shared Savings Program (MSSP) so that accountable care organizations (ACOs) take on risk faster creates a one-size-fits-all model that doesn’t allow for variability, said Joe Antos, PhD, the Wilson H. Taylor Resident Scholar in Health Care and Retirement Policy at the American Enterprise Institute.

Transcript

How do you think pushing more accountable care organizations (ACOs) to take on risk faster will impact participation in the MSSP?

I’m concerned about the new CMS regulation, because it’s not at all clear that giving ACOs 5 years, I believe it is, and you’re either successful or you’re out, necessarily makes sense. There’s a lot of variability in healthcare. That’s the problem. And there’s a lot of variability geographically, and a whole bunch of other factors are at work as well.

So, this one-size-fits-all—which, unfortunately, is pretty much the only way the government can set a rule—makes it difficult. I think, in the end, what people have predicted will probably come true, but it might be transitory. I think there will be ACOs who are now in the program who will drop out. There will be some discouragement factor there. Not as many organizations will try to become an ACO, until the kinks are worked out. I think that’s the issue. Because it’s not just “there’s a rule.” It’s, “well, how does CMS actually implement it and are there ways to deal with whatever the hard barriers are?” These are businesses—they’ll find ways.

Related Videos
Screenshot of Jennifer Vaughn, MD, in a Zoom video interview
Shawn Kwatra, MD, dermatologist, John Hopkins University
Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients with Plaque Psoriasis
dr krystyn van vliet
Martin Dahl, PhD, senior vice president, AnaptysBio
Jeff Stark, MD, vice president, head of medical immunology, UCB.
Jonathan Silverberg, MD, PhD, MPH, FAAD, professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences
Monica Li, MD, University of British Columbia
Robert Sidbury, MD, MPH, FAAD, professor of pediatrics, division head of dermatology, Seattle Children's Hospital, University of Washington School of Medicine
Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University Chicago Medical School, founder and director of the Center for Medical Dermatology and Immunology Research
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.